May 30, 2025
The Cardio-Pulmonary Institute (CPI) is among the selected Clusters of Excellence in the current funding line of the German Research Foundation (DFG) and will receive funding for another seven years.
Read moreMay 28, 2025
A better understanding of their condition can be crucial for the long-term treatment success of patients with Chronic Obstructive Pulmonary disease (COPD).
Read moreMay 20, 2025
An international research team led by DZL scientists Dr. Fenja Knoepp and Prof. Dr. Serge Adnot from Justus Liebig University Giessen (DZL site UGMLC) as well as Prof. Dr. Eric Honoré has uncovered a key mechanism involved in the development of pulmonary hypertension.
Read moreMay 12, 2025
In a recent study by DZL researchers at the UGMLC site, a previously unknown mechanism regulating the immune response in the lungs was identified. The findings were published in the prestigious journal Science Immunology.
Read moreMay 8, 2025
The opening meeting of the DZL DataLung School clearly highlighted the urgent need and importance of work at the intersection of biotechnology and artificial intelligence.
Read moreApril 28, 2025
Dr. Cheng-Yu Wu has received funding from UKGM to investigate the role of oxidative stress and vascular changes in chronic lung diseases such as COPD. The goal is to develop new therapeutic approaches.
Read moreApril 8, 2025
The ZENITH study shows promising results for Sotatercept in the treatment of advanced pulmonary arterial hypertension (PAH) and represents a significant advancement in the therapy of this severe disease.
Read moreMarch 21, 2025
Another important milestone at the Seltersberg medicine campus area: The topping-out ceremony for the Institute for Lung Health (ILH) of JLU was celebrated under bright sunshine.
Read moreFebruary 5, 2025
DZL researchers have developed a new theory on the development of pulmonary arterial hypertension (PAH). The focus is on lysosomes – cellular organelles responsible for metabolism and waste disposal.
Read moreJanuary 20, 2025
Dr. Cheng-Yu Wu, a DZL scientist at the Justus Liebig University Giessen (DZL site UGMLC), has been awarded a grant of €116,600 by the Von Behring-Röntgen-Stiftung.
Read moreNovember 22, 2024
Again this year, six Principal Investigators (PIs) from the German Center for Lung Research (DZL) are among the world’s most cited researchers.
Read moreNovember 20, 2024
Researchers at Philipps University Marburg (DZL site UGMLC) have made progress in the management of chronic obstructive pulmonary disease (COPD).
Read moreNovember 19, 2024
A small bite with devastating consequences: Each year, up to 100 million people worldwide contract Dengue fever, with the numbers on the rise.
Read moreNovember 8, 2024
An ATS workshop led by DZL scientist Prof. Mareike Lehmann brings together leading experts to advance precision-cut lung slices (PCLS) as a promising tool for the development of targeted therapies.
Read moreOctober 4, 2024
The German biobanking community met on September 23-24 for the 12th National Biobanking Symposium. Conference president PD Dr. Karoline Gaede, DZL scientist from the Research Center Borstel (ARCN site), welcomed about 200 participants in Berlin.
Read moreSeptember 26, 2024
A healthy lung can recover from small injuries caused by viruses or pollutants. However, this regenerative ability is impaired in patients with pulmonary fibrosis.
Read moreAugust 28, 2024
A recent study published in the scientific journal CHEST, led by DZL scientists from the Institute for Lung Health (ILH) in Gießen, investigated the effectiveness of various risk models for predicting different forms of Pulmonary Hypertension (PH).
Read moreAugust 21, 2024
Lung cancer remains the leading cause of cancer-related deaths in the U.S. and Europe. Despite available treatments, more than 70% of patients experience relapse and eventually succumb to the disease, often due to its spread to other parts of the body.
Read moreAugust 5, 2024
Pulmonary arterial hypertension (PAH) is a rare but serious condition characterized by high blood pressure in the arteries that connect the heart to the lungs. This disease leads to the narrowing and thickening of the arterial walls, which impairs blood flow and increases the pressure in the pulmonary arteries.
Read moreAugust 2, 2024
Lung cancer is the leading cause of cancer deaths worldwide. While early-stage lung cancer can often be treated with radical surgical interventions or chemotherapy, over 70% of patients experience recurrences, primarily due to the spread of the cancer to other parts of the body.
Read more
More news can be found on the DZL news site. The link below leads to a pre-filtered overview of all UGMLC-related news.